Medicament for treating irritable bowel syndrome with spleen-stomach damp-heat syndrome

Abstract

The invention provides a medicament for treating irritable bowel syndrome with spleen-stomach damp-heat syndrome, comprising medicinal materials: Radix Scutellariae, Rhizoma Coptidis, Herba Portulacae, Radix Sophorae Flavescentis, Radix Pulsatillae, Rhizoma Atractylodis, Semen Coicis, Poria, Radix Puerariae, Radix Curcumae, Fructus Aurantii, Rhizoma Cyperi, Pericarpium Citri Reticulatae, Pericarpium Citri Reticulatae, Cortex Magnoliae Officinalis, Radix Notoginseng, Radix Paeoniae Alba, Radix Paeoniae Rubra, Fructus Crataegi, Herba Lophatheri, Rhizoma Acori Tatarinowii and Radix Glycyrrhizae Preparata. The medicament is effective in clearing heat and eliminating damp, relieving spasm and pain and cooling blood and removing stasis through formulation compatibility with respect to traditional Chinese medicine differentiation of the irritable bowel syndrome with spleen-stomach damp-heat syndrome in connection with clinical manifestation of a patient. The medicament is well functional in treating a patient with the irritable bowel syndrome with spleen-stomach damp-heat syndrome in terms of clinical symptoms and living quality; can reduce recurrence of this disease, thus reducing anxiety and depression.

Description

technical field [0001] The invention relates to the technical field of traditional Chinese medicine, in particular to a medicine for treating irritable bowel syndrome of spleen-stomach damp-heat syndrome type. Background technique [0002] Irritable bowel syndrome (irritable bowel syndrome, IBS) is a functional bowel disease (functional bowel disease, FBD) characterized by abdominal pain or abdominal discomfort with changes in bowel habits. Limited to the colon, it is collectively referred to as irritable bowel syndrome. The disease lacks morphological changes and biochemical abnormalities that can explain the symptoms, and its incidence is increasing year by year, accounting for 25%-50% of digestive outpatient visits. According to the epidemiological survey, it is found that the disease is more common in women, with a male to female ratio of approximately 1:1 to 1:2, and the majority of the patients are middle-aged people aged 30 to 40. The prevalence of irritable bowel s...

AI Technical Summary

Problems solved by technology

At present, although medical workers at home and abroad have made unremitting exploration and efforts on the disease, because the etiology and pathogenesis of the disease are not completely clear, the current Western medicine treatment methods are still mainly symptomatic treatment, mainly antispasmodic, antispasmodic Drugs for intestinal peristalsis, drugs that relax gastrointestinal smooth muscle can be used for patients with obvious abdominal pain. At the same time, psychological counseling is given to patients with mental abnormalities, and anti-anxiety and anti-depressant drugs can be given if necessary, but the clinical efficacy is low. Symptoms come and go

Images